Evolent Health Inc. (NYSE:EVH) was up 2.8% during mid-day trading on Friday . The stock traded as high as $23.65 and last traded at $23.65, with a volume of 62,927 shares. The stock had previously closed at $23.00.

Several equities research analysts have recently issued reports on EVH shares. FBR & Co started coverage on shares of Evolent Health in a research note on Tuesday, March 29th. They issued an “outperform” rating and a $16.00 price objective on the stock. Canaccord Genuity reaffirmed a “buy” rating and issued a $30.00 target price on shares of Evolent Health in a research report on Wednesday, July 13th. Leerink Swann reaffirmed a “buy” rating and issued a $20.00 target price on shares of Evolent Health in a research report on Monday, May 16th. Finally, Zacks Investment Research raised Evolent Health from a “sell” rating to a “hold” rating in a research report on Wednesday, May 18th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $21.00.

The company has a market capitalization of $1.44 billion and a P/E ratio of 6.40. The stock’s 50-day moving average price is $18.70 and its 200 day moving average price is $13.04.

Evolent Health (NYSE:EVH) last announced its quarterly earnings data on Thursday, May 12th. The company reported ($0.16) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.19) by $0.03. The company had revenue of $49.50 million for the quarter, compared to the consensus estimate of $47.40 million. The company’s quarterly revenue was up 33.8% on a year-over-year basis. Equities analysts anticipate that Evolent Health Inc. will post ($0.62) EPS for the current year.

A hedge fund recently raised its stake in Evolent Health stock. Schroder Investment Management Group increased its position in Evolent Health Inc. (NYSE:EVH) by 120.1% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 355,922 shares of the company’s stock after buying an additional 194,222 shares during the period. Schroder Investment Management Group owned approximately 0.60% of Evolent Health worth $4,310,000 at the end of the most recent quarter.

Evolent Health, Inc supports integrated health systems in their migration towards value-based care and population health management. The Company’s services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and health plan administration services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.